Autor der Publikation

Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advance Hodgkin's disease. German Hodgkins' Study Group (GHSG)

, , , , , , , , , und . Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 6 (9): 901–910 (1995)

Bitte wählen Sie eine Person um die Publikation zuzuordnen

Um zwischen Personen mit demselben Namen zu unterscheiden, wird der akademische Grad und der Titel einer wichtigen Publikation angezeigt. Zudem lassen sich über den Button neben dem Namen einige der Person bereits zugeordnete Publikationen anzeigen.

 

Weitere Publikationen von Autoren mit dem selben Namen

Treatment of anaemia in myelodysplastic syndromes with prolonged administration of recombinant human granulocyte colony-stimulating factor and erythropoietin, , , , , , und . British journal of haematology, 109 (2): 367–375 (2000)BEACOPP: a new regimen for advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group, , , , , , , , , und 15 andere Autor(en). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, (1998)Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and adjuvant radiotherapy: a study of the German Hodgkin's Lymphoma Study Group, , , , , , , , , und 10 andere Autor(en). Blood, 92 (12): 4560–4567 (1998)BEACOPP: an intensified chemotherapy regimen in advanced Hodgkin's disease. The German Hodgkin's Lymphoma Study Group, , , , , , , , , und 1 andere Autor(en). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 8 (2): 143–148 (1997)Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease, , , , , , , , , und 15 andere Autor(en). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 15 (6): 2275–2287 (1997)Die Therapie des Morbus Hodgkin, , , , und . Der Internist, 39 (9): 917–926 (1998)Serum cytokine levels correlate with clinical parameters in Hodgkin's disease, , , , und . Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 6 (5): 477–482 (1995)Acute hematologic toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin's disease. German Hodgkin's Lymphoma Study Group (GHSG), , , , und . Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 11 (9): 1105–1114 (2000)Dose escalation of cytotoxic drugs using haematopoietic growth factors: a randomized trial to determine the magnitude of increase provided by GM-CSF, , , , , , , , , und 3 andere Autor(en). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 12 (4): 471–477 (2001)Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advance Hodgkin's disease. German Hodgkins' Study Group (GHSG), , , , , , , , , und . Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 6 (9): 901–910 (1995)